Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8831916 | International Journal of Surgery | 2018 | 29 Pages |
Abstract
Clinical stage correlates poorly with pathological stage in resectable pancreatic cancer. The majority of patients do not experience a change in stage with NAT. Those with early stage disease, responsive to NAT, experience a survival benefit.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Katelin A. Mirkin, Erin K. Greenleaf, Christopher S. Hollenbeak, Joyce Wong,